6. AstraZeneca

Total Ad Spend: $209.4 million
Television: $156.5 million
Magazine: $41 million
Other: $11.8 million

With stomach drug Nexium facing a patent loss, AstraZeneca ($AZN) pushed it hard last year, as well as its best-selling drug, cholesterol-fighter Crestor. It wasn't enough to keep both from losing ground, with sales declines of 6% and 3% respectively.

In the spotlight

Nexium, $57.6 million
Symbicort, $57.3 million
Crestor, $51.5 million



Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

That didn’t take long. Sanofi CEO Paul Hudson has only been at the reins for a couple months, but on Tuesday, he unveiled a major shakeup.  

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.